Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-02-08

Clinical Trial Update: Canadian eCLIPs™ Safety and Feasibility Study Protocol [Phase 1]

View source ↗

Summary

A Phase 1 safety and feasibility study protocol for the eCLIPs device in intracranial aneurysms has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eCLIPs

Snippet

Sponsor: Evasc Medical Systems Corp. | Conditions: Intracranial Aneurysms | Phase 1 | Status: WITHDRAWN